{"slug":"second-line","tag":"second-line","variants":["second-line"],"description":"No description yet","count":1,"kinds":{"person":1},"related":[{"slug":"car-t","tag":"car-t","shared":1},{"slug":"lymphoma","tag":"lymphoma","shared":1}],"records":[{"id":"jason-westin","kind":"person","name":"Jason R. Westin","route":"/people/jason-westin/","tldr":"Led the ZUMA-7 overall survival analysis that made CAR-T the standard second-line therapy for early-relapsing lymphoma."}]}